COSCIENS Biopharma Completes Share Consolidation and Split
UNVERIFIED·Primary source · Financial Post
COSCIENS Biopharma completed a share consolidation (1:150) followed by a share split (50:1).
Shareholders with fewer than 150 shares are entitled to a cash payment of US$1.60.
The company plans to file a Form 15 with the SEC to suspend U.S. reporting obligations.
Key Facts
01
01 — What / Thesis
COSCIENS Biopharma Completes Share Consolidation and Split
02
02 — Who / Subject
COSCIENS Biopharma Inc.
03
03 — Where / Locus
Toronto, Canada
04
04 — When / Temporality
July 3, 2026
AI Verification Note
This article is generated by cross-referencing multiple sources and official announcements. Parts relying solely on testimony or reporting are reflected in the confidence score; content and assessment are updated as new information is confirmed.
